Is Bonjesta in shortage in 2026? Get the latest update on Bonjesta availability, pricing, and what you can do if you can't find it at your pharmacy.
If you've been struggling to find Bonjesta at your local pharmacy, you're probably wondering: is Bonjesta in shortage? The short answer is that Bonjesta is not officially listed on the FDA Drug Shortage Database. But that doesn't tell the whole story.
Many pregnant women report difficulty finding Bonjesta at retail pharmacies, and the reasons have more to do with how the drug is distributed and covered by insurance than with an actual manufacturing shortage. In this article, we'll break down the current availability picture, what's driving the difficulty, and what your options are in 2026.
As of early 2026, Bonjesta is not in a formal drug shortage. Duchesnay USA, the manufacturer, continues to produce and distribute the medication. The supply chain from manufacturer to wholesaler is functioning normally.
However, "available from the manufacturer" and "available at your local pharmacy" are two different things. The real challenge for patients is at the last mile — getting a pharmacy near you to stock it.
This situation is sometimes called a "soft shortage" — the drug exists in the supply chain, but individual patients can't easily access it at their local pharmacy. It's a frustrating reality for many Bonjesta patients.
Several factors contribute to the availability challenges patients face:
Bonjesta serves a specific patient population — pregnant women with morning sickness who haven't responded to lifestyle changes. This relatively narrow indication means most pharmacies don't fill enough Bonjesta prescriptions to justify keeping it on their shelves. Chain pharmacies, which manage inventory centrally, may not stock it at locations where demand is low.
There is still no generic version of Bonjesta available in 2026. Without generic manufacturers adding to the supply, Duchesnay USA remains the sole producer. This means fewer total units in the market compared to medications with multiple generic manufacturers.
Many insurance plans, including major carriers like UnitedHealthcare, exclude Bonjesta from coverage or require prior authorization with step therapy. Patients are often required to try over-the-counter Doxylamine + vitamin B6 or Diclegis first. These insurance barriers reduce the number of Bonjesta prescriptions being filled, which in turn reduces pharmacy stocking.
For more details on why Bonjesta is hard to find, see our detailed guide.
The cost of Bonjesta varies significantly depending on how you access it:
The Bonjesta At Home program is often the best deal for patients paying out of pocket. Learn more in our guide to saving money on Bonjesta.
While there's no generic Bonjesta yet, patients have more options than ever for managing morning sickness:
If you need Bonjesta and can't find it at your regular pharmacy, here's what to do:
While Bonjesta is not in a formal shortage in 2026, the real-world experience for many patients feels like one. Limited pharmacy stocking, no generic option, and frequent insurance exclusions create a perfect storm of difficulty.
But there are solutions. The Bonjesta At Home program, pharmacy stock-checking tools like Medfinder, and alternative medications mean you don't have to go without relief from morning sickness.
Stay informed and know your options. For more information, explore our articles on what Bonjesta is and how to check pharmacy stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
